The first approved PH1 prescription medication for people of all ages and stages of kidney function.†*
OXLUMO® (lumasiran) is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood in children and adults.
OXLUMO works by reducing oxalate production in infants, children, and adults
OXLUMO is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood in children and adults.
What to expect from treatment with OXLUMO
Learn about how OXLUMO is given.
CONNECT WITH AN ALNYLAM EDUCATOR
Learn about primary hyperoxaluria type 1 (PH1) and treatment with OXLUMO® from one of our trained Alnylam Patient Education Liaisons (PELs).
PELs are employees of Alnylam Pharmaceuticals. They are not acting as healthcare providers and are not part of your healthcare team.
We’re here to help you access therapy
Find support services that can help you and your family during treatment with OXLUMO.